An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer

Lung Cancer

Volumn 32, Issue 2, 2001, Pages 145-153

  Van Sörnsen De Koste, John ^a   Voet, Peter ^a   Dirkx, Maarten ^a   Van Meerbeeck, Jan ^a   Senan, Suresh ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Beam intensity modulation; Chemotherapy; Conformal; Non small cell lung cancer; Radiation pneumonitis; Radiotherapy

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; HUMAN; LUNG NON SMALL CELL CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION PNEUMONIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGUS; FOLLOW-UP STUDIES; HEART; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDIASTINUM; NEOPLASM STAGING; PACLITAXEL; PARTICLE ACCELERATORS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, HIGH-ENERGY; TREATMENT OUTCOME;

EID: 0035040002     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00214-2     Document Type: Article

References (39)

1. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small-cell lung carcinoma
2. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: mature data from the randomised multicentre trial. CHART Steering Committee
3. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
4. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
5. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
6. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
7. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung
8. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients
9. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer
10. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
11. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001
12. Feasibility of curative radiotherapy with a concomitant boost technique in 33 patients with non-small cell lung cancer
13. X-ray field compensation with multileaf collimators
14. Generation of discrete beam-intensity modulation by dynamic multileaf collimation under minimum leaf separation constraints
15. Leaf trajectory calculation for dynamic multileaf collimation to realize optimized fluence profiles
16. Implementation of a three-dimensional compensation system based on computed tomography generated surface contours and tissue inhomogeneities
17. Compensators for three-dimensional treatment planning
18. Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation
19. The use of compensators to optimise the three dimensional dose distribution in radiotherapy of the intact breast
20. Beam intensity modulation using dynamic MLC in 3-DCRT of primary cancers of the oropharynx and larynx, including the elective neck
21. Field margin reduction using intensity-modulated X-ray beams formed with a multileaf collimator
22. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients
23. An analysis of anatomic landmark mobility and setup deviations in radiotherapy for lung cancer
24. Automatic calculation of three-dimensional margins around treatment volumes in radiotherapy planning
25. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) - analysis of a Radiation Therapy Oncology Group (RTOG) protocol
26. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index
27. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity
28. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems
29. Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer
30. Fraction size and dose parameters related to the incidence of pericardial effusions
31. Cardiac disease following treatment of Hodgkin's disease in children and adolescents
32. Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: a dosimetric study
33. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?
34. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography
35. The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation
36. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation
37. The use of active breathing control (ABC) to reduce margin for breathing motion